BioCorRx (QB) Stock Quote BICX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.52

Bid

0.47

Ask

0.8994

Volume

0.00 Day's Range 0.00

0.3515 52 Week Range 2.16

Market Cap

4.999M

Previous Close

0.52

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,779

Shares Outstanding

9,612,703

Dividend Yield

PE Ratio

-1.33

Earnings Per Share (EPS)

-0.39

Revenue

89k

Net Profit

-3.77M

BioCorRx Inc., through its subsidiaries, develops and provides innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCrave... BioCorRx Inc., through its subsidiaries, develops and provides innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The Company's majority owned subsidiary BioCorRx Pharmaceuticals Inc. is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Specifically, the Company is developing an implantable naltrexone (BICX104) with the goal of future regulatory approval with the Food and Drug Administration. For more information on BICX, visit www.BioCorRx.com. Show more

Sector

Spec Outpatient Facility,nec

Industry

Spec Outpatient Facility,nec

Website

www.biocorrx.com

Headquarters

Reno, Nevada, USA

Founded

1970

BioCorRx Inc (QB) is listed in the Spec Outpatient Facility sector of the OTCMarkets with ticker BICX. The last closing price for BioCorRx (QB) was $0.52. Over the last year, BioCorRx (QB) shares have traded in a share price range of $ 0.3515 to $ 2.16.

BioCorRx (QB) currently has 9,612,703 shares outstanding. The market capitalization of BioCorRx (QB) is $5 million. BioCorRx (QB) has a price to earnings ratio (PE ratio) of -1.33.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0.05	10.6382978723	0.47	0.55	0.47	628	0.47716106	CS
12	-0.26	-33.3333333333	0.78	0.9	0.3515	1779	0.58263927	CS
26	-0.22	-29.7297297297	0.74	1.5	0.3515	1700	0.80541959	CS
52	-1.64	-75.9259259259	2.16	2.16	0.3515	1851	0.97485243	CS
156	-3.57	-87.2860635697	4.09	7.5	0.2177	2024	2.33073614	CS
260	-3.03	-85.3521126761	3.55	8.1	0.155	2229	2.48136843	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M